Product NDC: | 0615-0531 |
Proprietary Name: | Hydralazine Hydrochloride |
Non Proprietary Name: | Hydralazine Hydrochloride |
Active Ingredient(s): | 25 mg/1 & nbsp; Hydralazine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0615-0531 |
Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA086961 |
Marketing Category: | ANDA |
Start Marketing Date: | 19800227 |
Package NDC: | 0615-0531-39 |
Package Description: | 30 TABLET in 1 BLISTER PACK (0615-0531-39) |
NDC Code | 0615-0531-39 |
Proprietary Name | Hydralazine Hydrochloride |
Package Description | 30 TABLET in 1 BLISTER PACK (0615-0531-39) |
Product NDC | 0615-0531 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hydralazine Hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19800227 |
Marketing Category Name | ANDA |
Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
Substance Name | HYDRALAZINE HYDROCHLORIDE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Arteriolar Vasodilation [PE],Arteriolar Vasodilator [EPC] |